TNF reduces LIF endocytosis despite increasing NFkappaB-mediated gp130 expression.
To examine how the proinflammatory cytokine tumor necrosis factor alpha (TNF) modulates the response of cerebral microvessels to other cytokines, we used rat cerebral microvessel endothelial RBE4 cells to simulate the in vitro blood-brain barrier (BBB). The gp130 receptor, which is shared by the interleukin (IL)-6 family of cytokines, showed specific upregulation by TNF. TNF treatment (5 ng/ml for 30 min to 24 h) increased gp130 at both the levels of transcription and protein expression. The stability of gp130 protein was mediated by NFkappaB activity, as the inhibitors quinazoline and MG132 not only blocked the increase induced by 6 h of TNF treatment, but also reduced its basal level of expression. By contrast, the lysosomal inhibitor chloroquine and the extracellular regulated kinase inhibitor U0126 showed no effect. Despite the increase of gp130, TNF caused a significant reduction in the cell binding and endocytosis of leukemia inhibitory factor (LIF), another proinflammatory cytokine that binds to the gp130 co-receptor and its unique gp190 receptor. This is consistent with our previous findings that TNF reduces gp190 expression and Stat3 activation. Thus, TNF stimulation results in decreased responsiveness of RBE4 cells to LIF, indicating complex regulatory interactions of cytokines at the BBB.
Yu
Chuanhui
C
Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808, USA.
Kastin
Abba J
AJ
Pan
Weihong
W
D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D050822:Cytokine Receptor gp130 / Q000235:genetics / Q000378:metabolism*; D017931:DNA Primers / Q000235:genetics; D004705:Endocytosis / Q000187:drug effects; D042783:Endothelial Cells / Q000187:drug effects / Q000378:metabolism; D015870:Gene Expression / Q000187:drug effects; D053605:Leukemia Inhibitory Factor / Q000378:metabolism*; D016328:NF-kappa B / Q000378:metabolism*; D046988:Proteasome Endopeptidase Complex / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D017931:DNA Primers; D053605:Leukemia Inhibitory Factor; D016328:NF-kappa B; D014409:Tumor Necrosis Factor-alpha; D050822:Cytokine Receptor gp130; D046988:Proteasome Endopeptidase Complex